Literature DB >> 28956647

Study of controlled-release floating tablets of dipyridamole using the dry-coated method.

Kai Chen1, Haoyang Wen1, Feifei Yang1, Yibin Yu1, Xiumei Gai1, Haiying Wang1, Pingfei Li1, Weisan Pan1, Xinggang Yang1.   

Abstract

Dipyridamole (DIP), having a short biological half-life, has a narrow absorption window and is primarily absorbed in the stomach. So, the purpose of this study was to prepare controlled-release floating (CRF) tablets of dipyridamole by the dry-coated method. The influence of agents with different viscosity, hydroxypropylmethylcellulose (HPMC) and polyvinylpyrollidon K30 (PVP K30) in the core tablet and low-viscosity HPMC and PVP K30 in the coating layer on drug release, were investigated. Then, a study with a three-factor, three-level orthogonal experimental design was used to optimize the formulation of the CRF tablets. After data processing, the optimized formulation was found to be: 80 mg HPMC K4M in the core tablet, 80 mg HPMC E15 in core tablet and 40 mg PVP K30 in the coating layer. Moreover, an in vitro buoyancy study showed that the optimized formulation had an excellent floating ability and could immediately float without a lag time and this lasted more than 12 h. Furthermore, an in vivo gamma scintigraphic study showed that the gastric residence time of the CRF tablet was about 8 h.

Entities:  

Keywords:  Dipyridamole; buoyancy; controlled-release floating tablets; gamma scintigraphic; orthogonal experimental design

Mesh:

Substances:

Year:  2017        PMID: 28956647     DOI: 10.1080/03639045.2017.1386198

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  1 in total

1.  Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.

Authors:  Dongyang Fang; Yining Yang; Mengsuo Cui; Hao Pan; Lijie Wang; Pingfei Li; Wenjing Wu; Sen Qiao; Weisan Pan
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.